Browse > Article
http://dx.doi.org/10.4014/jmb.2009.09005

Enterococcus faecium R0026 Combined with Bacillus subtilis R0179 Prevent Obesity-Associated Hyperlipidemia and Modulate Gut Microbiota in C57BL/6 Mice  

Huang, Jinli (Department of Microecology, College of Basic Medical Sciences, Dalian Medical University)
Huang, Juan (Department of Microecology, College of Basic Medical Sciences, Dalian Medical University)
Yin, Tianyi (First Affiliated Hospital of Dalian Medical University)
Lv, Huiyun (First Affiliated Hospital of Dalian Medical University)
Zhang, Pengyu (Department of Microecology, College of Basic Medical Sciences, Dalian Medical University)
Li, Huajun (Department of Microecology, College of Basic Medical Sciences, Dalian Medical University)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.2, 2021 , pp. 181-188 More about this Journal
Abstract
Bacillus subtilis and Enterococcus faecium are commonly used probiotics. This study aimed to identify the effect of live combined Bacillus subtilis R0179 and Enterococcus faecium R0026 (LCBE) on obesity-associated hyperlipidemia and gut microbiota in C57BL/6 mice. Forty male C57BL/6 mice were divided into four groups: normal group (N group), model group (M group), low-dose group (L group), and high-dose group (H group). Mice were gavaged with LCBE at 0.023 g/mice/day (L group) or 0.23 g/mice/day (H group) and fed with a high-fat diet for 8 weeks. In vitro E. faecium R0026 showed an ability to lower the low-concentration of cholesterol by 46%, and the ability to lower the high-concentration of cholesterol by 58%. LCBE significantly reduced the body weight gain, Lee index, brown fat index and body mass index of mice on a high-fat diet. Moreover, LCBE markedly improved serum lipids (including serum triglyceride, total cholesterol, low-density lipoprotein and high-density lipoprotein) while also significantly reducing liver total cholesterol. Serum lipopolysaccharide and total bile acid in L and H groups decreased significantly compared with M group. PCR-DGGE analysis showed that the composition of gut microbiota in the treatment groups was improved. Akkermansia muciniphila was found in H group. The PCA result indicated a similar gut microbiota structure between LCBE treatment groups and normal group while the number of bands and Shannon diversity index increased significantly in the LCBE treatment groups. Finally, qPCR showed Bifidobacterium spp. increased significantly in H group compared with M group, LCBE alleviated liver steatosis and improved brown adipose tissue index.
Keywords
Adiposity; probiotics; microflora; inflammation; serum lipids;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Klop B, Elte J, Cabezas M. 2013. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients 5: 1218-1240.   DOI
2 Boden G. 2011. Obesity, insulin resistance and free fatty acids. Curr. Opin. Endocrinol. Diabetes Obes. 18: 139-143.   DOI
3 Jain RB, Ducatman A. 2018. Roles of gender and obesity in defining correlations between perfluoroalkyl substances and lipid/lipoproteins. Sci. Total Environ. 653: 74-81.   DOI
4 Franssen R, Monajemi H, Stroes ES, Kastelein JJ. 2011. Obesity and dyslipidemia. Med. Clin. North Am. 95: 893-902.   DOI
5 Manichanh C, Rigottier-Gois L, Bonnaud E, Gloux K, Pelletier E, Frangeul L, et al. 2006. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 55: 205-211.   DOI
6 Zeng J, Li YQ, Zuo XL, ZhenYB, Yang J, Liu CH. 2008. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther. 28: 994-1002.   DOI
7 Schmittgen TD, Livak KJ. 2008. Analyzing Real-Time PCR data by the comparative C (T) method. Nat. Protoc. 3: 1101-1108.   DOI
8 Chen G, Xie M, Wan P, Chen D, Dai Z, Ye H, et al. 2018. Fuzhuan brick tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota. J. Agric. Food Chem. 66: 2783-2795.   DOI
9 Hamad EM, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, et al. 2009. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br. J. Nutr. 101: 716-724.   DOI
10 Ma X, Hua J, Li Z. 2008. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J. Hepatol. 49: 821-30.   DOI
11 Dylag K, Hubalewska-Mazgajm M, Surmiak M, Szmyd J, Brzozowski T. 2014. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr. Pharm. Des. 20: 1149-1155.   DOI
12 Chen JJ, Wang R, Li XF, Wang RL. 2011. Bifidobacterium longum supplementation improved high-fat-fed-induced metabolic syndrome and promoted intestinal Reg I gene expression. Exp. Biol. Med. 236: 823-831.   DOI
13 Bagci U, Togay SO, Temi A, Ay M. 2019. Probiotic characteristics of bacteriocin-producing Enterococcus faecium strains isolated from human milk and colostrum. Folia Microbiologica 64: 735-750.   DOI
14 Jin Y, Tian Y, Zhang W. 2010. Tracking bacterial infection into macrophages by a novel red-emissionp H sensor. Anal. Bioanal. Chem. 398: 1375-1384.   DOI
15 Ley RE, Turnbaugh PJ, Klein S, Gordon JI. 2006. Human gut microbes associated with obesity. Nature 444: 1022-3.   DOI
16 Di BJ, Frank D, Mathur R. 2012. Impact of the gut Microbiota on the development of the obesity-the. Am. J. Gastroenterol. 1: 22-27.   DOI
17 Cavallini DCU, Abdalla DSP, Vendramini RC, Bedani R, Bomdespacho LQ, Pauly-Silveira ND, et al. 2009. Intake of isoflavone-supplemented soy yogurt fermented with Enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. Eur. Food Res. Technol. 228: 275-282.   DOI
18 Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, et al. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim. Biophys. Acta 1761: 736-744.   DOI
19 Kang JH, Yun SI, Park HO. 2010. Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J. Microbiol. 48: 712-714.   DOI
20 Karimaei S, Sadeghi J, Asadian M, Esghaei M, Pourshafie MR, Talebi M. 2016. Antibacterial potential and genetic profile of Enterococcus faecium strains isolated from human normal flora. Microb. Pathog. 96: 67-71.   DOI
21 Singhal N, Maurya AK, Mohanty S, Kumar M, Virdi JS. 2019. Evaluation of bile salt hydrolases, cholesterol-lowering capabilities, and probiotic potential of Enterococcus faecium isolated from Rhizosphere. Front. Microbiol. 10: 1567.   DOI
22 Stanford KI, Middelbeek RJ, Townsend KL, An D, Nygaard EB, Hitchcox KM, et al. 2013. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J. Clin. Invest. 123: 215-23.   DOI
23 Qiao Y, Sun J, Xia SF, Tang X, Shi YH, Le GW. 2014. Effects of resveratrol on gut microbiota and fat storage in a mouse model with high-fat-induced obesity. Food Funct. 5: 1241-2149.   DOI
24 Quan LH, Zhang C, Dong M, Jiang J. 2020. Myristoleic acid produced by enterococci reduces obesity through brown adipose tissue activation. Gut 69: 1239-1247.   DOI
25 Huang H, Lin Z, Zeng Y, Lin X, Zhang Y. 2019. Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model. Exp. Ther. Med. 18: 4733-4739.
26 Selvam R, Maheswari P, Kavitha P, Ravichandran M, Sas B, Ramchand CN. 2009. Effect of Bacillus subtilis PB6, a natural probiotic on colon mucosal inflammation and plasma cytokines levels in inflammatory bowel disease. Indian J. Biochem. Biophys. 46: 79-85.
27 Everard A, Belzer C, Geurts L. 2013. Cross-talk between Akkermansia muciniphilaand intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110: 9066-71.   DOI
28 Zhang HL, Li WS, Xu DN, Zheng WW, Liu Y, Chen J, et al. 2016. Mucosa-repairing and microbiota-balancing therapeutic effect of Bacillus subtilis alleviates dextrate sulfate sodium-induced ulcerative colitis in mice. Exp. Ther. Med. 12: 2554-2562.   DOI
29 Walker A, Pfitzner B, Harir M, Schaubeck M, Calasan J, Heinzmann SS, et al. 2017. Sulfonolipids as novel metabolite markers of Alistipes and Odoribacter affected by high-fat diets. Sci. Rep. 7: 11047.   DOI
30 Kondoh M, Shimada T, Fukada K, Morita M, Katada K, Higashimura Y, et al. 2014. Beneficial effects of heat-treated Enterococcus faecalis FK-23 on high-fat diet-induced hepatic steatosis in mice. Br. J. Nutr. 112: 868-875.   DOI
31 Aly SM, Abdel-Galil AY, Abdel-Aziz GA, Mohamed MF. 2008. Studies on Bacillus subtilis and Lactobacillus acidophilus, as potential probiotics, on the immune response and resistance of Tilapia nilotica (Oreochromis niloticus) to challenge infections. Fish Shellfish Immunol. 25: 128-136.   DOI
32 Hanifi A, Culpepper T, Mai V, Anand A, Ford AL, Ukhanova M, et al. 2015. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Benef. Microbes 6: 19-27.   DOI
33 Kim JY, Jeong JE, Moon SH, Park KY. 2010. Antiobesity Effect of the Bacillus subtilis KC-3 Fermented Soymilk in 3T3-L1 Adipocytes. J. Korean Soc. Food Sci. Nutr. 39: 1126-1131.   DOI
34 Tompkins TA., Hagen KE, Wallace TD, Fillion-Forte V. 2008. Safety evaluation of two bacterial strains used in asian probiotic products. Can. J. Microbiol. 54: 391-400.   DOI
35 Guo M, Li YQ, Zuo XL. 2006. The role of Treg/CD4 + T in the pathogenesis and prevention of bowel dysfunction after acute enteritis in rats. Chin. J. Dig. 26: 435-439.   DOI
36 Tompkins T, Xu X, Ahmarani J. 2010. A comprehensive review of post-market clinical studies performed in adults with an asian probiotic formulation. Benef. Microbes 1: 93-106.   DOI
37 Wang QS, Xiang YZ, Cui YL, Lin KM, Zhang XF. 2012. Dietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2 expression via the NF-κB inactivation. PLoS One 7: e34122.   DOI
38 Albano C, Morandi S, Silvetti T, Casiraghi MC, Manini F, Brasca M. 2018. Lactic acid bacteria with cholesterol-lowering properties for dairy applications: in vitro and in situ activity. J. Dairy Sci. 101: 10807-10818.   DOI
39 Ohno H, Kizaki T, Ohishi S, Yamashita H, Tanaka J, Gasa S. 1995. Effects of swimming training on the lysosomal enzyme system in brown adipose tissue of rats: an analogy between swimming exercise and cold acclimation. Acta Physiol. Scand. 155: 333-334.   DOI
40 Chen QC, Liu M, Zhang PY, Fan SJ, Huang JL, Yu SY, et al. 2019. Fucoidan and galactooligosaccharides ameliorate high-fat diet induced dyslipidemia in rats by modulating the gut microbiota and bile acid metabolism. Nutrition 65: 50-59.   DOI
41 He K, Hu Y, Ma H, Zou Z, Xiao Y, Yang Y, et al. 2016. Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. Biochim. Biophys. Acta 1862: 1696-1709.   DOI
42 Fasoli S, Marzotto M, Rizzotti L, Rossi F, Dellaglio F, Torriani S. 2003. Bacterial composition of commercial probiotic products as evaluated by PCR-DGGE analysis. Int. J. Food Microbiol. 82: 59-70.   DOI
43 Sanchez O, Gasol JM, Massana R, Mas J, Pedros-Alio C. 2007. Comparison of different denaturing gradient gel electrophoresis primer sets for the study of marine bacterioplankton communities. Appl. Environ. Microbiol. 73: 5962-5967.   DOI
44 Zhong YT, Zhang WP, Wang XL, Huang X, MA Li. 2006. The bacteriostatic effect of Medilac-Vita on enteric pathogen and conditioned pathogen and their bacterial L form. Ganan Yixueyuan Xuebao. 26: 487-488